Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting
We have designed AS1411-N6, a derivative of the nucleolin (NCL)-binding aptamer AS1411, by adding six nucleotides to the 5'-end that are complementary to nucleotides at the 3'-end forcing it into a stem-loop structure. We evaluated by several biophysical techniques if AS1411-N6 can adopt o...
Saved in:
Main Authors: | André Miranda (Author), Tiago Santos (Author), Eric Largy (Author), Carla Cruz (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma
by: Kyeongjin Seo, et al.
Published: (2024) -
Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imaging
by: Nithya Subramanian, et al.
Published: (2016) -
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
by: Lin Zhang, et al.
Published: (2022) -
AS1411-functionalized delivery nanosystems for targeted cancer therapy
by: Pooria Safarzadeh Kozani, et al.
Published: (2021) -
The Bioactivity of D-/L-Isonucleoside- and 2'-Deoxyinosine-Incorporated Aptamer AS1411s Including DNA Replication/MicroRNA Expression
by: Xinmeng Fan, et al.
Published: (2017)